NEPENTHE
COVID-19
Prince Sattam Bin Abdulaziz UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
14 Active assets in the COVID-19 cohort.
View all 25 →
Same molecule, other indications
NEPENTHE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →